FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erol Bayburt

Research Profile

Chemicals & Drugs

Concepts & Ideas

Living Beings

Disorders

Procedures

Administration, Oral

Anatomy

Genes & Molecular Sequences

Molecular Structure

Phenomena

Magnetic Resonance Spectroscopy

Co-author Network

Publications

TOP 3
Robert G Schmidt; Erol K Bayburt; Steven P Latshaw; John R Koenig; Jerome F Daanen; Heath A McDonald; Bruce R Bianchi; Chengmin Zhong; Shailen Joshi; Prisca Honore; Kennan Marsh; Chih-Hung Lee; Connie R Faltynek; Arthur Gomtsyan
Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists.
Carol S Surowy; Torben R Neelands; Bruce R Bianchi; Steve McGaraughty; Rachid El Kouhen; Ping Han; Katharine L Chu; Heath A McDonald; Melissa Vos; Wende Niforatos; Erol K Bayburt; Arthur Gomtsyan; Abel Lee; Prisca Honore; James P Sullivan; Michael F Jarvis; Connie R Faltynek
(R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
Arthur Gomtsyan; Erol K Bayburt; Robert G Schmidt; Carol S Surowy; Prisca Honore; Kennan Marsh; Steven M Hannick; Heath A McDonald; Jill M Wetter; James P Sullivan; Michael F Jarvis; Connie R Faltynek; Abel Lee
Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erol Bayburt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Robert G Schmidt; Erol K Bayburt; Steven P Latshaw; John R Koenig; Jerome F Daanen; Heath A McDonald; Bruce R Bianchi; Chengmin Zhong; Shailen Joshi; Prisca Honore; Kennan Marsh; Chih-Hung Lee; Connie R Faltynek; Arthur Gomtsyan
Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists.
Bioorganic & medicinal chemistry letters 2011;21(5):1338-41.
2008: Carol S Surowy; Torben R Neelands; Bruce R Bianchi; Steve McGaraughty; Rachid El Kouhen; Ping Han; Katharine L Chu; Heath A McDonald; Melissa Vos; Wende Niforatos; Erol K Bayburt; Arthur Gomtsyan; Abel Lee; Prisca Honore; James P Sullivan; Michael F Jarvis; Connie R Faltynek
(R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
The Journal of pharmacology and experimental therapeutics 2008;326(3):879-88.
2008: Arthur Gomtsyan; Erol K Bayburt; Robert G Schmidt; Carol S Surowy; Prisca Honore; Kennan Marsh; Steven M Hannick; Heath A McDonald; Jill M Wetter; James P Sullivan; Michael F Jarvis; Connie R Faltynek; Abel Lee
Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management.
Journal of medicinal chemistry 2008;51(3):392-5.
2007: Richard J Perner; Stanley Didomenico; John R Koenig; Arthur Gomtsyan; Erol K Bayburt; Robert G Schmidt; Irene Drizin; Guo Zhu Zheng; Sean C Turner; Tammie K Jinkerson; Brian S Brown; Ryan G Keddy; Kurill Lukin; Heath A McDonald; Prisca Honore; Joe Mikusa; Kennan Marsh; Jill M Wetter; Karen St George; Michael F Jarvis; Connie R Faltynek; Abel Lee
In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonists.
Journal of medicinal chemistry 2007;50(15):3651-60.
2007: Arthur Gomtsyan; Erol K Bayburt; Ryan G Keddy; Sean C Turner; Tammie K Jinkerson; Stanley Didomenico; Richard J Perner; John R Koenig; Irene Drizin; Heath A McDonald; Carol S Surowy; Prisca Honore; Joe Mikusa; Kennan Marsh; Jill M Wetter; Connie R Faltynek; Abel Lee
Alpha-methylation at benzylic fragment of N-aryl-N'-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model.
Bioorganic & medicinal chemistry letters 2007;17(14):3894-9.
2006: M Cui; Prisca Honore; Chengmin Zhong; Donna M Gauvin; Joe Mikusa; Gricelda Hernandez; Prasant Chandran; Arthur Gomtsyan; B Brown; Erol K Bayburt; Kennan Marsh; Bruce R Bianchi; Heath McDonald; Wende Niforatos; Torben R Neelands; Robert B Moreland; Michael W Decker; Chih Hung Lee; James P Sullivan; Connie R Faltynek
TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(37):9385-93.
2006: Irene Drizin; Arthur Gomtsyan; Erol K Bayburt; Robert G Schmidt; Guo Zhu Zheng; Richard J Perner; Stanley Didomenico; John R Koenig; Sean C Turner; Tammie K Jinkerson; Brian S Brown; Ryan G Keddy; Heath A McDonald; Prisca Honore; Carol T Wismer; Kennan Marsh; Jill M Wetter; James S Polakowski; Jason A Segreti; Michael F Jarvis; Connie R Faltynek; Abel Lee
Structure-activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonists.
Bioorganic & medicinal chemistry 2006;14(14):4740-9.
2005: Richard J Perner; Abel Lee; Meiqun Jiang; Yu Gui Gu; Stanley Didomenico; Erol K Bayburt; Easaw Alexander; Kathy L Kohlhaas; Michael F Jarvis; Elizabeth L Kowaluk; Shripad S Bhagwat
Synthesis and biological evaluation of 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidines as adenosine kinase inhibitors.
Bioorganic & medicinal chemistry letters 2005;15(11):2803-7.
2005: Mark A Matulenko; Abel Lee; Meiqun Jiang; Robin R Frey; Marlon D Cowart; Erol K Bayburt; Stanley Didomenico; Gregory A Gfesser; Arthur Gomtsyan; Guo Zhu Zheng; Jeffrey A McKie; Andrew O Stewart; Haixia Yu; Kathy L Kohlhaas; Easaw Alexander; Steve McGaraughty; Carol T Wismer; Joe Mikusa; Kennan Marsh; Ronald D Snyder; Marilyn S Diehl; Elizabeth A Kowaluk; Michael F Jarvis; Shripad S Bhagwat
5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure-activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors.
Bioorganic & medicinal chemistry 2005;13(11):3705-20.
2005: Arthur Gomtsyan; Erol K Bayburt; Robert G Schmidt; Guo Zhu Zheng; Richard J Perner; Stanley Didomenico; John R Koenig; Sean Turner; Tammie K Jinkerson; Irene Drizin; Steven M Hannick; Bryan S Macri; Heath A McDonald; Prisca Honore; Carol T Wismer; Kennan Marsh; Jill M Wetter; Kent D Stewart; Tetsuro Oie; Michael F Jarvis; Carol S Surowy; Connie R Faltynek; Abel Lee
Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.
Journal of medicinal chemistry 2005;48(3):744-52.
2003: Richard J Perner; Yu Gui Gu; Abel Lee; Erol K Bayburt; Jeffrey A McKie; Easaw Alexander; Kathy L Kohlhaas; Carol T Wismer; Joe Mikusa; Michael F Jarvis; Elizabeth A Kowaluk; Shripad S Bhagwat
5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel inhibitors of adenosine kinase.
Journal of medicinal chemistry 2003;46(24):5249-57.
2003: Gregory A Gfesser; Erol K Bayburt; Marlon D Cowart; Stanley Didomenico; Arthur Gomtsyan; Chih Hung Lee; Andrew O Stewart; Michael F Jarvis; Elizabeth A Kowaluk; Shripad S Bhagwat
Synthesis and structure-activity relationships of 5-heteroatom-substituted pyridopyrimidines as adenosine kinase inhibitors.
European journal of medicinal chemistry 2003;38(3):245-52.
2001: Marlon D Cowart; Chih Hung Lee; Gregory A Gfesser; Erol K Bayburt; Shripad S Bhagwat; Andrew O Stewart; Haixia Yu; Kathy L Kohlhaas; Steve McGaraughty; Carol T Wismer; Joe Mikusa; Chang Zhu; Easaw Alexander; Michael F Jarvis; Elizabeth A Kowaluk
Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors.
Bioorganic & medicinal chemistry letters 2001;11(1):83-6.
2000: Philip J Hajduk; Arthur Gomtsyan; Stanley Didomenico; Marlon D Cowart; Erol K Bayburt; Larry Solomon; Jean M Severin; Richard Smith; Karl Walter; Thomas F Holzman; A Stewart; Steve McGaraughty; Michael F Jarvis; Elizabeth A Kowaluk; Stephen W Fesik
Design of adenosine kinase inhibitors from the NMR-based screening of fragments.
Journal of medicinal chemistry 2000;43(25):4781-6.
1999: Yu Gui Gu; Erol K Bayburt; Michael R Michaelides; Chun W Lin; K Shiosaki
trans-2,6-,3,6- and 4,6-diaza-5,6,6a,7,8,12b-hexahydro-benzo[c]phenanthrene-10,11- diols as dopamine agonists.
Bioorganic & medicinal chemistry letters 1999;9(10):1341-6.
1997: Michael R Michaelides; Y Hong; Stanley Didomenico; Erol K Bayburt; K E Asin; DR Britton; Chun W Lin; K Shiosaki
Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo.
Journal of medicinal chemistry 1997;40(11):1585-99.